WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Corp Earnings & Revenue

KTTA past revenue growth

How has KTTA's revenue growth performed historically?
Company
1,498.14%
Industry
192.99%
Market
18.52%
KTTA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KTTA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KTTA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KTTA earnings and revenue history

Current Revenue
$240.7k
Current Earnings
-$16.0M
Current Profit Margin
-6,659.9%

KTTA Return on Equity

Current Company
-44%
Current Industry
15.4%
Current Market
-8.4%
KTTA's Return on Equity (-44%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KTTA announces earnings.

KTTA Return on Assets

Current Company
-41.1%
Current Industry
2.2%
KTTA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KTTA Return on Capital Employed

Current Company
-56%
Current Industry
17.7%

KTTA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KTTA$240.71k-$15.46M-$16.03M+1,498.14%N/A
TOVX$0.00-$20.69M-$18.46MN/AN/A
SCPX$2.23M-$48.05M-$51.96M-12.53%N/A
ABVC$739.26k-$9.67M-$12.27M+27.36%N/A
APM$1.20M-$11.65M-$13.40M+114.11%N/A

KTTA earnings dates

Next earnings date
Mar 30, 2024

Pasithea Therapeutics Earnings & Revenue FAQ

What were KTTA's earnings last quarter?

On Invalid Date, Pasithea Therapeutics (NASDAQ: KTTA) reported Q3 2023 earnings per share (EPS) of -$2.80, up 17.65% year over year. Total Pasithea Therapeutics earnings for the quarter were -$3.61 million. In the same quarter last year, Pasithea Therapeutics's earnings per share (EPS) was -$3.40.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.

What was KTTA's earnings growth in the past year?

As of Q1 2024, Pasithea Therapeutics's earnings has grown year over year. Pasithea Therapeutics's earnings in the past year totalled -$16.03 million.

What is KTTA's earnings date?

Pasithea Therapeutics's earnings date is Invalid Date. Add KTTA to your watchlist to be reminded of KTTA's next earnings announcement.

What was KTTA's revenue last quarter?

On Invalid Date, Pasithea Therapeutics (NASDAQ: KTTA) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Pasithea Therapeutics's revenue was $0.00.

What was KTTA's revenue growth in the past year?

As of Q1 2024, Pasithea Therapeutics's revenue has grown 1,498.14% year over year. This is 1,305.15 percentage points higher than the US Biotechnology industry revenue growth rate of 192.99%. Pasithea Therapeutics's revenue in the past year totalled $240.71 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.